Azenta, Inc.
General ticker "AZTA" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.6B (TTM average)
Azenta, Inc. follows the US Stock Market performance with the rate: 25.5%.
Estimated limits based on current volatility of 1.5%: low 38.93$, high 40.15$
Factors to consider:
- Total employees count: 3300 (-5.7%) as of 2024
- US accounted for 55.8% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: Geopolitical risks, Regulatory and compliance, Currency fluctuations, Customer concentration and demand forecasting, Supply chain disruptions
- Earnings for 12 months up through Q4 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [39.14$, 61.67$]
- 2025-09-30 to 2026-09-30 estimated range: [36.61$, 58.87$]
Financial Metrics affecting the AZTA estimates:
- Negative: with PPE of 119.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 8.64 > -0.62
- Positive: Industry inventory ratio change (median), % of 0.28 <= 0.28
- Positive: Shareholder equity ratio, % of 84.23 > 64.17
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of -1.08 <= -0.76
Short-term AZTA quotes
Long-term AZTA plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $555.50MM | $665.07MM | $656.32MM |
| Operating Expenses | $580.23MM | $738.20MM | $857.00MM |
| Operating Income | $-24.73MM | $-73.13MM | $-200.68MM |
| Non-Operating Income | $14.80MM | $42.69MM | $33.35MM |
| Interest Expense | $4.59MM | $0.00MM | $0.00MM |
| R&D Expense | $27.54MM | $33.96MM | $33.52MM |
| Income(Loss) | $-9.94MM | $-30.43MM | $-167.32MM |
| Taxes | $1.35MM | $-17.55MM | $-3.15MM |
| Other Income(Loss) | $2,144.14MM | $-1.37MM | $0.00MM |
| Profit(Loss)* | $-11.29MM | $-15.63MM | $-164.17MM |
| Stockholders Equity | $3,363.39MM | $2,534.50MM | $1,768.97MM |
| Inventory | $85.54MM | $128.20MM | $115.26MM |
| Assets | $3,716.12MM | $2,885.72MM | $2,100.04MM |
| Operating Cash Flow | $-466.05MM | $17.49MM | $50.29MM |
| Capital expenditure | $77.44MM | $39.44MM | $37.39MM |
| Investing Cash Flow | $1,465.59MM | $431.38MM | $224.74MM |
| Financing Cash Flow | $-62.76MM | $-844.08MM | $-659.21MM |
| Earnings Per Share** | $-0.15 | $-0.24 | $-3.09 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.